Phase I/II Multiple-Dose LEA29Y vs CTLAG4Ig vs Placebo in Rheumatoid Arthritis
Clinical trial NCT00279760 · COMPLETED
Trial details
- NCT number
- NCT00279760
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Primary completion
- 2002-03-01
- Enrollment
- 210
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.